Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64926 - 64950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	CRIP1	1396	downregulated	resveratrol results in decreased expression of CRIP1 mRNA	14q32.33	A22289
Resveratrol	Investigational	CSF2	1437	upregulated	resveratrol results in increased expression of CSF2 mRNA	5q31.1	A23859
Resveratrol	Investigational	CSNK2A2	1459	upregulated	resveratrol results in increased expression of CSNK2A2 mRNA	16q21	A22289
Resveratrol	Investigational	CST4	1472	upregulated	resveratrol results in increased expression of CST4 mRNA	20p11.21	A23908
Resveratrol	Investigational	CTGF	1490	downregulated	resveratrol results in decreased expression of CTGF mRNA	6q23.2	A23893
Resveratrol	Investigational	CTHRC1	115908	upregulated	resveratrol results in increased expression of CTHRC1 mRNA	8q22.3	A23852
Resveratrol	Investigational	CTNNB1	1499	downregulated	resveratrol results in decreased expression of CTNNB1 mRNA	3p22.1	A23912 A23913
Resveratrol	Investigational	CTSD	1509	upregulated	resveratrol metabolite results in increased expression of CTSD mRNA	11p15.5	A20106
Resveratrol	Investigational	CTSD	1509	downregulated	resveratrol results in decreased expression of CTSD mRNA	11p15.5	A22733
Resveratrol	Investigational	CTSD	1509	upregulated	resveratrol results in increased expression of CTSD mRNA	11p15.5	A23876
Resveratrol	Investigational	CUX1	1523	downregulated	resveratrol results in decreased expression of CUX1 mRNA	7q22.1	A22289
Resveratrol	Investigational	CX3CL1	6376	downregulated	resveratrol results in decreased expression of CX3CL1 mRNA	16q21	A23893
Resveratrol	Investigational	CXCL1	2919	downregulated	resveratrol results in decreased expression of CXCL1 mRNA	4q13.3	A23914
Resveratrol	Investigational	CXCL10	3627	downregulated	resveratrol results in decreased expression of CXCL10 mRNA	4q21.1	A20456 A20457
Resveratrol	Investigational	CXCL2	2920	downregulated	resveratrol results in decreased expression of CXCL2 mRNA	4q13.3	A23893
Resveratrol	Investigational	CXCL2	2920	upregulated	resveratrol results in increased expression of CXCL2 mRNA	4q13.3	A23852
Resveratrol	Investigational	CXCL6	6372	downregulated	resveratrol results in decreased expression of CXCL6 mRNA	4q13.3	A23893
Resveratrol	Investigational	CXCL8	3576	downregulated	resveratrol analog results in decreased expression of CXCL8 mRNA	4q13.3	A23915
Resveratrol	Investigational	CXCL8	3576	downregulated	resveratrol results in decreased expression of CXCL8 mRNA	4q13.3	A20456 A23893 A20460
Resveratrol	Investigational	CXCL8	3576	downregulated	[resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of CXCL8 mRNA	4q13.3	A23916
Resveratrol	Investigational	CXCL8	3576	upregulated	resveratrol results in increased expression of CXCL8 mRNA	4q13.3	A23859 A23902 A20457 A23853 A20460
Resveratrol	Investigational	CXCR4	7852	downregulated	resveratrol results in decreased expression of CXCR4 mRNA	2q22.1	A23859
Resveratrol	Investigational	CYB5R2	51700	upregulated	resveratrol results in increased expression of CYB5R2 mRNA	11p15.4	A23852
Resveratrol	Investigational	CYCS	54205	upregulated	resveratrol results in increased expression of CYCS mRNA	7p15.3	A23888 A23848
Resveratrol	Investigational	CYGB	114757	downregulated	resveratrol results in decreased expression of CYGB mRNA	17q25.1	A21627

Displaying entries 64926 - 64950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability